16/10/2026 US FDA approved Roche’s satralizumab for TED US FDA approved UCB’s zilucoplan autoinjector adults with gMG US FDA approved Roche’s satralizumab for TED (Ref) Roche’s Enspryng® (satralizumab; IL-6R inhibitor) received US FDA approval as the first and only at-home subcutaneous treatment for adults with thyroid eye disease (TED).The approval was based on Ph3, SatraGO-1 and SatraGO -2 studies. SatraGO-2 showed a significant reduction in proptosis and improvement in dip